FDA Clears Tm Bioscience Cystic Fibrosis Gene Test Via De Novo
This article was originally published in The Gray Sheet
Executive Summary
FDA's de novo clearance of Tm Bioscience's Tag-It cystic fibrosis test kit paves the way for other CFTR gene mutation detection assays to be categorized as Class II